Publicacións en colaboración con investigadores/as de Hospital Ramón y Cajal (11)

2024

  1. Practical use of new therapies for the management of dyslipidaemias. Consensus SEC/SEA/SEEN/SEMFYC/SEMERGEN/SEMG/SEN/SEACV/S.E.N.

    REC: CardioClinics, Vol. 59, Núm. 4, pp. 310-321

2021

  1. Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 765-772

  2. Direct Oral Anticoagulants Versus Vitamin-K Antagonist After PCIs in Patients With AF: A Meta-analysis of Cardiac Ischemic Events

    Journal of cardiovascular pharmacology, Vol. 77, Núm. 2, pp. 164-169

  3. Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS

    REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20

  4. Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48

  5. Prognosis impact of diabetes in elderly women and men with non-st elevation acute coronary syndrome

    Journal of Clinical Medicine, Vol. 10, Núm. 19

2014

  1. Temas de actualidad en cardiología: riesgo vascular y rehabilitación cardiaca

    Revista Espanola de Cardiologia, Vol. 67, Núm. 3, pp. 203-210

2013

  1. Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care

    BMC Family Practice, Vol. 14

2011

  1. Short-term metabolic changes achieved by weight loss in hypertensive patients

    International Journal of Cardiology, Vol. 153, Núm. 3, pp. 286-290

2010

  1. Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents

    Cardiovascular Therapeutics, Vol. 28, Núm. 1, pp. 15-22

2008

  1. Adiponectina, un factor de riesgo cardiovascular emergente. Estudio REFERENCE

    Revista Espanola de Cardiologia, Vol. 61, Núm. 11, pp. 1159-1167